Indy Hematology Review

http://www.indyhematologyreview.com/

 

Targeting Mutations in Myeloma with Venetoclax and Development of the First MM Platform Trial - MyDRUG

415 views
June 24, 2019
0 Comments
Login to view comments. Click here to Login
Indy Hematology Review 2019 Conference